Bio-Rad Laboratories Inc (BIO) — Strategic Asset Allocation Index
Bio-Rad Laboratories Inc (BIO) has a Strategic Asset Allocation Index of 77.5% as of March 2026. Strategic assets (PP&E of $- plus long-term investments of $5.31 Billion) total $5.31 Billion, measured against net assets of $6.85 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Bio-Rad Laboratories Inc (BIO) net asset quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Bio-Rad Laboratories Inc Strategic Asset Allocation Index (2000–2025)
This chart shows how Bio-Rad Laboratories Inc's Strategic Asset Allocation Index has evolved across 26 annual periods from 2000 to 2025. As of March 2026, the index stands at 77.5%, representing strategic assets of $5.31 Billion against net assets of $6.85 Billion USD. For live market cap and overall valuation, see Bio-Rad Laboratories Inc market cap and net worth.
Annual Strategic Asset Allocation Index for Bio-Rad Laboratories Inc (2000–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Bio-Rad Laboratories Inc from 2000 to 2025, covering 26 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Bio-Rad Laboratories Inc (BIO) net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 91.4% | $6.81 Billion | $709.90 Million | $6.10 Billion | $7.45 Billion | ▲ +7.3 pp |
| 2024 | 84.1% | $5.53 Billion | $688.60 Million | $4.84 Billion | $6.57 Billion | ▼ -12.2 pp |
| 2023 | 96.3% | $8.42 Billion | $723.74 Million | $7.70 Billion | $8.74 Billion | ▼ -0.7 pp |
| 2022 | 97.0% | $9.33 Billion | $498.61 Million | $8.83 Billion | $9.62 Billion | ▼ -13.2 pp |
| 2021 | 110.2% | $15.08 Billion | $695.75 Million | $14.39 Billion | $13.69 Billion | ▲ +8.5 pp |
| 2020 | 101.7% | $10.05 Billion | $491.37 Million | $9.56 Billion | $9.88 Billion | ▲ +12.5 pp |
| 2019 | 89.3% | $5.14 Billion | $499.34 Million | $4.64 Billion | $5.76 Billion | ▲ +10.6 pp |
| 2018 | 78.7% | $3.16 Billion | $508.69 Million | $2.66 Billion | $4.02 Billion | ▲ +26.8 pp |
| 2017 | 51.9% | $1.52 Billion | $493.50 Million | $1.03 Billion | $2.93 Billion | ▲ +0.8 pp |
| 2016 | 51.2% | $1.32 Billion | $488.61 Million | $830.79 Million | $2.58 Billion | ▲ +4.7 pp |
| 2015 | 46.5% | $1.16 Billion | $437.69 Million | $719.84 Million | $2.49 Billion | ▲ +9.0 pp |
| 2014 | 37.4% | $818.14 Million | $428.84 Million | $389.31 Million | $2.19 Billion | ▲ +0.5 pp |
| 2013 | 36.9% | $807.23 Million | $429.36 Million | $377.87 Million | $2.19 Billion | ▲ +16.2 pp |
| 2012 | 20.7% | $416.94 Million | $416.94 Million | $- | $2.02 Billion | ▲ +0.7 pp |
| 2011 | 20.0% | $349.50 Million | $349.50 Million | $- | $1.74 Billion | ▲ +18.8 pp |
| 2010 | 1.2% | $18.46 Million | $18.46 Million | $- | $1.54 Billion | ▼ -22.4 pp |
| 2009 | 23.6% | $302.42 Million | $302.42 Million | $- | $1.28 Billion | ▼ -4.4 pp |
| 2008 | 28.1% | $300.73 Million | $300.73 Million | $- | $1.07 Billion | ▲ +0.1 pp |
| 2007 | 27.9% | $271.56 Million | $271.56 Million | $- | $971.69 Million | ▲ +4.8 pp |
| 2006 | 23.1% | $189.63 Million | $189.63 Million | $- | $819.54 Million | ▼ -4.3 pp |
| 2005 | 27.4% | $180.26 Million | $180.26 Million | $- | $657.97 Million | ▼ -6.5 pp |
| 2004 | 33.9% | $202.32 Million | $202.32 Million | $- | $596.89 Million | ▼ -2.2 pp |
| 2003 | 36.1% | $179.12 Million | $179.12 Million | $- | $495.81 Million | ▼ -1.0 pp |
| 2002 | 37.1% | $142.24 Million | $142.24 Million | $- | $383.09 Million | ▼ -9.7 pp |
| 2001 | 46.8% | $132.97 Million | $132.97 Million | $- | $283.88 Million | ▼ -1.8 pp |
| 2000 | 48.7% | $119.03 Million | $119.03 Million | $- | $244.62 Million | — |